On (b)(6) 2013, 3m espe was informed about an adverse event that occurred after 3m, espe, cavit was used together with other dental products.One pt got a dental root treatment on (b)(6).Within 24 hours the pt developed hives and the next day the pt did pass out while he was having breakfast.The pt was transported by ambulance to the emergency room where he was treated.In the meantime the pt is doing well, hives have lessened but are still present.At the date of this report it is not clear if cavit has caused the symptoms.
|
Method, results and conclusion: no product was returned to 3m espe for evaluation until the date of this report.An interview was conducted to the pt's doctor.The doctor spoke to the md and the md diagnosed a drug reaction.The pt just finished a penicillium prescription several days before the dental treatment.Another product used in the dental treatment was the local anaesthetic cetacaine.The pt had other root canal treatments before with any reaction.These data make an allergic reaction to cavit questionable.This product has been assessed for biocompatibility and has been found to be safe for its intended use.It is a long time in the market and has a favorable clinical use history, in which only two other reports of hospitalization after use has been received by 3m espe in 2008 (9611385-2008-00006) and 2012 (9611385-2012-00004).
|